"The voice for cancer physicians and their patients in Massachusetts."

Conquer Cancer Foundation Young Investigator’s Grant Program

The Massachusetts Society of Clinical Oncologists (MSCO) is proud to announce that we are collaborating and supporting the Conquer Cancer Foundation Young Investigator’s Grant Program. The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in oncology. The grant supports pre-clinical and clinical cancer research projects by oncologists who are undergoing a career transition from a fellowship program to a faculty appointment.


A Phase 1 study of adding navitoclax to the combination of venetoclax and decitabine for advanced myeloid malignancies.

Evan Chen, MD a third year Hematology/Oncology fellow at the Dana-Farber Cancer Institute (DFCI). He is a clinical investigator-in-training who seeks to improve precision medicine for myeloid malignancies through the clinical trial development of novel therapeutics and the retrospective study of their real-world outcomes. He is currently helping to lead a phase I study of navitoclax added to the combination of venetoclax and hypomethylating agents for advanced myeloid malignancies. He will be joining the Division of Leukemia at DFCI later this year.


A Phase 2 trial of palbociclib in combination with axitinib and avelumab in metastatic clear cell renal cell carcinoma.

Praful Ravi, MBBChir, MRCP, a Medical Oncologist at the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, is the recipient of the inaugural YIA Award supported by MSCO.

Quality and Innovation Grant

The purpose of the MSCO Quality & Innovation Grant is to improve the care of patients in the state of Massachusetts living with a diagnosis of cancer. Funding will be provided for an individual or a group seeking to improve the deliver of cancer care, the quality of cancer care, treatment of cancer, or comfort of patients suffering from cancer.

Previous Grant Recipients


Adapting the Electronic Patient Reported Outcomes (EPRO) Intervention to Improve Cancer Care Delivery and Clinical Outcomes of Limited-English Proficiency (LEP) Individuals Diagnosed with Advanced Gastrointestinal or Breast Cancer

Nadine McCleary, MD, MPH


Oral Chemotherapy Management with Electronic Patient Reporting--A Community and Academic Hybrid Model 

Jessica Zerillo, MD, PhD and Meghan Shea, MD

A Bundle to Standardize Home Medication Administration and Reduce Errors in Pediatric Oncology Patients 

Chris Wong Quiles, MD, MPH, CPPS


Feasibility, acceptability and effectiveness of the MBSR for smoking cessation in cancer patients

Marjory Charlot, MD, MPH, MSc

Massachusetts Society of Clinical Oncologists ©2022

PO BOX 549154, Waltham, MA, 02454
Tel: 781.434.7329  |  Fax: 781.464.4896  |  email: msco@mms.org

Powered by Wild Apricot Membership Software